OpenAI IPO Filing Possible This Week Sources Say Mastercard Secures New York BitLicense to Advance Stablecoin and Tokenized Deposit Initiatives Nvidia Earnings in Focus Jensen Huangs Commentary on China Chip Export Controls and Political Landscape Could Move Markets NYT Connections Game Maintains Popularity Highlighting New York Times Digital Engagement Katahdin Bankshares Declares 023 Quarterly Dividend Arafura Rare Earths to Raise A350 Million Backed by Hancock Prospecting for Nolans Project OPCH Q1 2026 Earnings EPS Beat Drives Modest Stock Decline BJ Q1 2026 Earnings EPS Beats Estimates but Shares Slide 825 on Mixed Signals Origin Bancorp OBK Q1 2026 Earnings EPS Misses Estimates Stock Slips MGRC Q1 2026 Earnings EPS Falls Short of Estimates Shares Inch Higher DHIL Q1 2025 Earnings EPS of 323 Reported Amidst Market Uncertainty Commerce Bancshares CBSH Q1 2026 Earnings EPS Beats Estimates by 7 Stock Edges Higher TPG Mortgage Investment Trust MITT Consolidates Near 763 as Support and Resistance Levels Hold Lumentum Holdings LITE Slightly Lower Amid Sector Rotation Key Levels in Focus Utz Brands Holds Steady Near Support as Snack Sector Faces Headwinds Regal Rexnord RRX Tests Key Resistance as Shares Rally 224 Howmet Aerospace HWM Surges 208 Testing Key Resistance Near 275 Nifty 50 Volatility Index Drops Over 100 Points After Briefly Reclaiming 24000 Level Bank Of Montreal BMO Q1 2026 Earnings EPS Beats Estimates by 644 as Bank Delivers Solid Profitability Pioneer Acquisition I Corp Warrants PACHW Trading Flat at 020 Amidst Consolidation Weatherford International Q1 2026 Earnings Strong EPS Beat Highlights Operational Discipline BeyondSpring BYSI Q1 2026 Earnings Narrowing Loss and No Revenue as ClinicalStage Biotech Advances Pipeline Galaxy Digital Inc GLXY Q1 2026 Earnings EPS Miss and Stock Decline Amid Crypto Market Volatility Northrop Grumman NOC Q1 2026 Earnings EPS Edges Past Estimates in Quiet Quarter TPCS Q1 2026 Earnings Modest Losses Amidst Operational Focus GLMD Q4 2025 Earnings EPS Misses Estimates Amid Development Stage Uncertainty Collegium Pharmaceutical Q1 2026 Earnings EPS Surpasses Estimates Amid Strategic Execution